| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25fd405acea430a0051b6eb7fb30395a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a3c763d912c1f039d8e731cceca821f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0041 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 |
| filingDate |
2018-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40de1b730939c8b7e7a4248895600221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65cd095a63e35e84c19354a617d10761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afad24f90d8ab454d3dcd6e3c7656022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6da9947bfeb3038d65d4dfaa8db5e366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3307041f36b3b5342fe9e3b6410112ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5680e3d1a4631c99c7e93b86da72ab9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d272c7abada1d9b3b030dd884f2534a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_135d79e2acd7a66017ac0d165d5f6551 |
| publicationDate |
2020-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111093717-A |
| titleOfInvention |
therapeutic nanoparticles |
| abstract |
Disclosed herein is a composition comprising a plurality of liposomes having an average diameter of less than 400 nanometers, wherein the plurality of liposomes comprise: a first lipid or phospholipid; a second polymer derivatized Lipids or phospholipids; sterically hindered bulky excipients capable of stabilizing the liposomes; third lipids or phospholipids derivatized with polymers capped with integrin targeting moieties; derivatized with groups that bind contrast enhancers The fourth lipid or phospholipid or DSPE, wherein the plurality of liposomes optionally encapsulate a payload component consisting of one or more biologically active agents. |
| priorityDate |
2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |